A Phase I Clinical Study of SSS59 Monotherapy in Patients With Advanced Malignant Tumors

Clinical trial NCT06944444 · RECRUITING

Trial details

NCT number: NCT06944444
Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Tumors

Start date: 2025-04-27
Primary completion: 2027-03-01
Enrollment: 154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.